Mindfulness Training for Mood Disorders
(BEAM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if mindfulness training can help early adolescents at high risk for mood disorders, such as depression or bipolar disorder, manage their emotions better. Researchers will compare two groups: one will engage in mindfulness-based exercises (Mindfulness-Based Intervention or MBI), while the other will focus on general health and wellness topics. The study targets young people aged 11-14 who have a parent or sibling with a major mood disorder and frequently experience rapid mood changes. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could enhance emotional management strategies for young people.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have changed medications or doses in the past two months, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that mindfulness-based programs are generally safe and well-tolerated, with few side effects. They have been used to help with anxiety, depression, stress, and other conditions. Studies have found that these programs can improve emotional management, making them a safe choice for addressing mood issues.
The Health and Wellness Intervention (HWI) aims to enhance health aspects like sleep, exercise, and nutrition. Although detailed safety data specifically for HWI is not available, similar health programs usually present no major safety concerns. They support overall well-being and are designed to be accessible for young people.
In summary, both mindfulness-based and health and wellness programs appear to be safe options based on current research and the nature of these programs.12345Why are researchers excited about this trial?
Researchers are excited about Mindfulness-Based Intervention (MBI) for mood disorders because it offers a fresh approach, emphasizing mindfulness rather than medication or traditional psychotherapy. Unlike standard treatments like antidepressants or cognitive-behavioral therapy, MBI focuses on teaching young people mindfulness practices to help them manage their thoughts and emotions in real-time. This method encourages participants to become more aware of their present experiences, which can lead to improved emotional regulation and reduced stress. Moreover, involving parents in the process and integrating weekly home practices make this intervention a holistic experience that could foster better communication and understanding within families, potentially enhancing its effectiveness.
What evidence suggests that this trial's treatments could be effective for mood disorders?
Research has shown that mindfulness-based interventions (MBI), which participants in this trial may receive, can effectively improve mood disorders. Studies have found that MBI significantly enhances mood, with a strong impact measured at about 0.95. These interventions help reduce symptoms of anxiety and depression, similar to cognitive behavioral therapy (CBT). In contrast, the Health and Wellness Intervention (HWI), another treatment option in this trial, is somewhat effective in managing stress and anxiety but generally has a smaller effect on depression. Overall, stronger evidence supports MBI for improving mood-related issues.678910
Who Is on the Research Team?
Danella Hafeman, MD, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for early adolescents aged 11-13 with high mood swings and a family history of major depression or bipolar disorder. They must not have metal in their body, recent suicidal thoughts, medication changes within two months, an IQ below 70, significant learning disabilities, or certain psychiatric diagnoses.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intake Assessment
Intake assessment to confirm diagnosis and obtain necessary data for eligibility
Treatment
Participants receive an 8-week mindfulness-based intervention (MBI) or health and wellness program (HWI)
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Health and Wellness Intervention
- Health-Enhancement Program
- MBI
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator